Skip to content
Norton & Elaine Sarnoff Center for Jewish Genetics Logo
  • Home
  • Get Screened
  • About Us
    • Board Members
    • Staff
  • Genetic Disorders
    • Types of Genetic Disorders
    • Jewish Genetic Disorder FAQs
    • Rabbinical Insights
  • Hereditary Cancer
    • BRCA Mutations
    • Lynch Syndrome
    • Assess Your Risk
    • Cancer FAQs
    • Cancer Resources
  • Resources
    • Preimplantation Genetic Testing
    • Family Health History
    • Teach Jewish Genetics
    • Community Resources
    • Educational Brochures
    • For Medical Professionals
    • Personal Stories
    • Blog
  • Get Involved
    • Events
    • Donate
Previous Next

Biotin-Thiamine-Responsive Basal Ganglia Disease

Biotin-thiamine-responsive basal ganglia disease (BTBGD) is a condition that affects how the body uses an important vitamin called thiamine (vitamin B1).

Thiamine is essential for the nervous system to work correctly. When thiamine levels drop, often due to fever, illness, or stress, it can cause problems with movement. Symptoms can include muscle stiffness, weakness, or trouble with balance and coordination. Muscles in the face can also be affected, leading to difficulties with chewing, swallowing, speaking, or moving the eyes. BTBGD comes in three forms: classic BTBGD (early childhood encephalopathy), early infantile Leigh-like syndrome, and adult-onset Wernicke-like encephalopathy.

Classic BTBGD: This is the most common form. Symptoms usually start between ages 3 and 10 and include seizures, abnormal muscle movements, weakness, and confusion. These symptoms often occur in episodes triggered by illness or stress. Without treatment, these episodes can be severe and may lead to coma or death.

Early Infantile Leigh-like Syndrome:  This is the most severe form and begins in the first three months of life. The symptoms are similar to the classic form but can cause more damage to the brain. Babies may have trouble feeding, vomit frequently, and have worsening seizures over time.

Adult-Onset Wernicke-like Encephalopathy:  This is the rarest and mildest form of BTBGD. Symptoms usually appear in the teens or twenties and include seizures, abnormal eye movements, and difficulty walking.

BTBGD is treated using supplements of high-dose thiamine (vitamin B1) and/or biotin (vitamin B7). Some individuals with muscle weakness or difficulty with moving or speaking may benefit from physical, occupational, and speech therapies.

This group of conditions is caused by pathogenic (disease-causing) variants in the SLC19A3 gene and exhibits autosomal recessive inheritance. This means that both parents must be carriers to have a 25% chance of having a child with the condition. The risk of being a carrier is based on a person’s ancestry or ethnic background.

Resources:  

GeneReviews

Medline Plus

Written August 2024

Scott Weissman2024-08-22T02:07:00+00:00August 22, 2024|

Share This Story, Choose Your Platform!

FacebookXRedditLinkedInWhatsAppTumblrPinterestVkXingEmail

About the Author: Scott Weissman

The Norton & Elaine Sarnoff Center for Jewish Genetics is a supporting foundation of the Jewish United Fund, and is supported in part by the Michael Reese Health Trust.

30 S Wells
Chicago, IL 60606
312-357-4718
jewishgenetics@juf.org

About
  • About Us
  • Genetic Disorders
  • Hereditary Cancer
  • Donate
Resources
  • Medical Professionals
  • Teach Jewish Genetics
  • Events

©2025 Norton & Elaine Sarnoff Center for Jewish Genetics

Page load link
Go to Top